Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|4|566-569

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.4, 2012-02, pp. : 566-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Cannabis Increase the Suicide Risk in Psychosis? A Critical Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5165-5187

Bentham Science Publishers

Access to resources Recommend Favorite

Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities

By  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 399-415

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of Fractures with Glitazones: A Critical Review of the Evidence to Date

By Bodmer Michael  

Drug Safety, Vol. 32, Iss. 7, 2009-07 ,pp. : 539-547

Adis International

Access to resources Recommend Favorite

Glutamate and Psychosis Risk

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 466-478

Bentham Science Publishers

Access to resources Recommend Favorite